Conflicting Data Leave Some Doubt About OA Role for GLP-1s

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

Weight loss from glucagon-like peptide 1 agonists clearly alleviates knee osteoarthritis pain, but other recently published data give pause regarding possible long-term adverse effects.
Medscape Medical News